134 related articles for article (PubMed ID: 35695119)
1. Effect of estrogen on vaginal complications of pessary use: a systematic review and meta-analysis.
Ai F; Wang Y; Wang J; Zhou L; Wang S
Climacteric; 2022 Dec; 25(6):533-542. PubMed ID: 35695119
[TBL] [Abstract][Full Text] [Related]
2. Pessaries (mechanical devices) for managing pelvic organ prolapse in women.
Bugge C; Adams EJ; Gopinath D; Stewart F; Dembinsky M; Sobiesuo P; Kearney R
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD004010. PubMed ID: 33207004
[TBL] [Abstract][Full Text] [Related]
3. Effect of vaginal estrogen in postmenopausal women using vaginal pessary for pelvic organ prolapse treatment: a randomized controlled trial.
Chiengthong K; Ruanphoo P; Chatsuwan T; Bunyavejchevin S
Int Urogynecol J; 2022 Jul; 33(7):1833-1838. PubMed ID: 33991221
[TBL] [Abstract][Full Text] [Related]
4. Effect of vaginal estrogen on pessary use.
Dessie SG; Armstrong K; Modest AM; Hacker MR; Hota LS
Int Urogynecol J; 2016 Sep; 27(9):1423-9. PubMed ID: 26992727
[TBL] [Abstract][Full Text] [Related]
5. Does vaginal estrogen treatment with support pessaries in vaginal prolapse reduce complications?
Bulchandani S; Toozs-Hobson P; Verghese T; Latthe P
Post Reprod Health; 2015 Dec; 21(4):141-5. PubMed ID: 26537626
[TBL] [Abstract][Full Text] [Related]
6. Effect of Local Estrogen Cream on Vaginal Health after Pessary Use for Prolapsed Pelvic Organ: A Randomized Controlled Trial.
Tontivuthikul P; Sanmee U; Wongtra-Ngan S; Pongnarisorn C
J Med Assoc Thai; 2016 Jul; 99(7):757-63. PubMed ID: 29901374
[TBL] [Abstract][Full Text] [Related]
7. An Arterial Vaginal Bleed Resulting from Short-Term Pessary Use: A Case Report.
Rieben K; Epp A
J Obstet Gynaecol Can; 2021 Apr; 43(4):503-505. PubMed ID: 33153940
[TBL] [Abstract][Full Text] [Related]
8. A tailored flexible vaginal pessary treatment for pelvic organ prolapse in older women.
Gold RS; Baruch Y; Amir H; Gordon D; Groutz A
J Am Geriatr Soc; 2021 Sep; 69(9):2518-2523. PubMed ID: 33979457
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of a continuous-use ring-shaped vaginal pessary without support for advanced pelvic organ prolapse in postmenopausal women.
Dueñas JL; Miceli A
Int Urogynecol J; 2018 Nov; 29(11):1629-1636. PubMed ID: 29478114
[TBL] [Abstract][Full Text] [Related]
10. ESTROgen use for complications in women treating pelvic organ prolapse with vaginal PESSaries (ESTRO-PESS)-a randomized clinical trial.
de Albuquerque Coelho SC; Giraldo PC; Brito LGO; Juliato CRT
Int Urogynecol J; 2021 Jun; 32(6):1571-1578. PubMed ID: 33501563
[TBL] [Abstract][Full Text] [Related]
11. Vaginal Pessary for Pelvic Organ Prolapse: A French Multidisciplinary Survey.
Pizzoferrato AC; Nyangoh-Timoh K; Martin-Lasnel M; Fauvet R; de Tayrac R; Villot A
J Womens Health (Larchmt); 2022 Jun; 31(6):870-877. PubMed ID: 34569823
[No Abstract] [Full Text] [Related]
12. Parameters associated with unsuccessful pessary fitting for pelvic organ prolapse up to three months follow-up: a systematic review and meta-analysis.
Manzini C; Morsinkhof LM; van der Vaart CH; Withagen MIJ; Grob ATM
Int Urogynecol J; 2022 Jul; 33(7):1719-1763. PubMed ID: 35037973
[TBL] [Abstract][Full Text] [Related]
13. Perioperative interventions in pelvic organ prolapse surgery.
Haya N; Feiner B; Baessler K; Christmann-Schmid C; Maher C
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD013105. PubMed ID: 30121957
[TBL] [Abstract][Full Text] [Related]
14. Management of incarcerated vaginal pessaries.
Poma PA
J Am Geriatr Soc; 1981 Jul; 29(7):325-7. PubMed ID: 7240622
[TBL] [Abstract][Full Text] [Related]
15. Discontinuation rate and adverse events after 1 year of vaginal pessary use in women with pelvic organ prolapse.
Yimphong T; Temtanakitpaisan T; Buppasiri P; Chongsomchai C; Kanchaiyaphum S
Int Urogynecol J; 2018 Aug; 29(8):1123-1128. PubMed ID: 28815277
[TBL] [Abstract][Full Text] [Related]
16. Predictors for long-term adherence to vaginal pessary in pelvic organ prolapse: a prospective study.
Niigaki DI; Silva RSP; Bortolini MAT; Fitz FF; Castro RA
Int Urogynecol J; 2022 Nov; 33(11):3237-3246. PubMed ID: 35286427
[TBL] [Abstract][Full Text] [Related]
17. A 5-year prospective study of vaginal pessary use for pelvic organ prolapse.
Lone F; Thakar R; Sultan AH; Karamalis G
Int J Gynaecol Obstet; 2011 Jul; 114(1):56-9. PubMed ID: 21575953
[TBL] [Abstract][Full Text] [Related]
18. Vaginal Pessary in Women With Symptomatic Pelvic Organ Prolapse: A Randomized Controlled Trial.
Cheung RY; Lee JH; Lee LL; Chung TK; Chan SS
Obstet Gynecol; 2016 Jul; 128(1):73-80. PubMed ID: 27275798
[TBL] [Abstract][Full Text] [Related]
19. Predictors for dislodgment of vaginal pessary within one year in women with pelvic organ prolapse.
Cheung RYK; Lee LLL; Chung TKH; Chan SSC
Maturitas; 2018 Feb; 108():53-57. PubMed ID: 29290215
[TBL] [Abstract][Full Text] [Related]
20. Risk Factors for Dislodgment of Vaginal Pessaries in Women With Pelvic Organ Prolapse: A Cohort Study.
Coelho SCA; Giraldo PC; de Castro EB; Brito LGO; Juliato CRT
Female Pelvic Med Reconstr Surg; 2021 Jan; 27(1):e247-e251. PubMed ID: 32487886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
